Zobrazeno 1 - 10
of 66
pro vyhledávání: '"William Wachsman"'
Autor:
Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang, Mat Makowski, Elshafa Hassan Ahmed, Sarah Schlotter, Rebecca Pearson, Rhonda Kitzler, Anna Mozhenkova, Jennifer Le-Rademacher, Richard F. Little, Gorgun Akpek, Ernesto Ayala, Steven M. Devine, Lawrence D. Kaplan, Ariela Noy, Uday R. Popat, Jack W. Hsu, Lawrence E. Morris, Adam M. Mendizabal, Amrita Krishnan, William Wachsman, Nita Williams, Nidhi Sharma, Craig C. Hofmeister, Stephen J. Forman, Willis H. Navarro, Joseph C. Alvarnas, Richard F. Ambinder, Gerard Lozanski, Robert A. Baiocchi
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
We report a first in-depth comparison of immune reconstitution in patients with HIV-related lymphoma following autologous hematopoietic cell transplant (AHCT) recipients (n=37, lymphoma, BEAM conditioning), HIV(-) AHCT recipients (n=30, myeloma, melp
Externí odkaz:
https://doaj.org/article/11e102a0fff440d19a1c2e8eecf7cba8
Autor:
Joseph A. Sparano, Jeannette Y. Lee, Lawrence D. Kaplan, Juan Carlos Ramos, Richard F. Ambinder, William Wachsman, David Aboulafia, Ariela Noy, David H. Henry, Lee Ratner, Ethel Cesarman, Amy Chadburn, Ronald Mitsuyasu
Publikováno v:
Haematologica, Vol 106, Iss 3 (2020)
Four cycles of rituximab plus CHOP chemotherapy is as effective as 6 cycles in low-risk diffuse large B-cell lymphoma (DLBCL). Here we report a post-hoc analysis of a prospective clinical trial in patients with HIV-associated DLBCL and high-grade lym
Externí odkaz:
https://doaj.org/article/078d20628e604f39b442cee01904788e
Supplementary Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Autor:
William Wachsman, Ronald Mitsuyasu, Robert Baiocchi, Toby Maurer, Elizabeth Yu Chiao, David Aboulafia, Dirk P. Dittmer, Otoniel Martínez-Maza, Semi Han, Jack D. Bui, Richard F. Ambinder, Page Moore, Kelly Shimabukuro, Erin G. Reid
Supplementary Data from AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::363d84ff46d51c141fc72087788491a6
https://doi.org/10.1158/1078-0432.22482903.v1
https://doi.org/10.1158/1078-0432.22482903.v1
Autor:
William Wachsman, Ronald Mitsuyasu, Robert Baiocchi, Toby Maurer, Elizabeth Yu Chiao, David Aboulafia, Dirk P. Dittmer, Otoniel Martínez-Maza, Semi Han, Jack D. Bui, Richard F. Ambinder, Page Moore, Kelly Shimabukuro, Erin G. Reid
Purpose:Kaposi sarcoma (KS), an endothelial cell tumor associated with KS herpesvirus (KSHV), remains among the most common malignancies occurring with HIV infection (HIV-KS). As an oral anti-inflammatory, antiangiogenic, and immunomodulatory agent,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::84574c6515d7cf55b78e89e9903fa915
https://doi.org/10.1158/1078-0432.c.6531033
https://doi.org/10.1158/1078-0432.c.6531033
Autor:
William Wachsman, Mark A. Dickson, Ronald Mitsuyasu, David Aboulafia, Robert J. Gorelick, Frank Maldarelli, Richard F. Ambinder, Dirk P. Dittmer, Shelly Y. Lensing, Adrienne Suazo, Erin G. Reid
Purpose:AIDS-related Kaposi sarcoma is often incompletely controlled, requiring serial therapies. Kaposi sarcoma herpesvirus (KSHV) induces transformation of endothelial cells, where it resides in a predominately latent state. We hypothesized proteas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::670457123e4178159acb057973d5f431
https://doi.org/10.1158/1078-0432.c.6528564.v1
https://doi.org/10.1158/1078-0432.c.6528564.v1
Autor:
William Wachsman, Mark A. Dickson, Ronald Mitsuyasu, David Aboulafia, Robert J. Gorelick, Frank Maldarelli, Richard F. Ambinder, Dirk P. Dittmer, Shelly Y. Lensing, Adrienne Suazo, Erin G. Reid
Supplementary Methods and Figure Supplemental Figure 1. Images demonstrating improvement in KS lesions in two patients obtaining partial response to bortezomib despite receiving treatment in the lowest 2 dose cohorts. Both patients met criteria for p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::66c348a9a96cbc4eca2aaeaf9514e187
https://doi.org/10.1158/1078-0432.22473618
https://doi.org/10.1158/1078-0432.22473618
Autor:
Erin G, Reid, Kelly, Shimabukuro, Page, Moore, Richard F, Ambinder, Jack D, Bui, Semi, Han, Otoniel, Martínez-Maza, Dirk P, Dittmer, David, Aboulafia, Elizabeth Yu, Chiao, Toby, Maurer, Robert, Baiocchi, Ronald, Mitsuyasu, William, Wachsman
Publikováno v:
Clinical Cancer Research. 28:2646-2656
Purpose:Kaposi sarcoma (KS), an endothelial cell tumor associated with KS herpesvirus (KSHV), remains among the most common malignancies occurring with HIV infection (HIV-KS). As an oral anti-inflammatory, antiangiogenic, and immunomodulatory agent,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ca0643668b6ced2da1f0005aa91d578
https://doi.org/10.1158/1078-0432.ccr-21-0645
https://doi.org/10.1158/1078-0432.ccr-21-0645
Autor:
Polina Shindiapina, Maciej Pietrzak, Michal Seweryn, Eric McLaughlin, Xiaoli Zhang, Mat Makowski, Elshafa Ahmed, Rebecca Pearson, Rhonda Kitzler, Jennifer G. Le-Rademacher, Richard F Little, Görgün Akpek, Ernesto Ayala, Steven M. Devine, Lawrence D. Kaplan, Ariela Noy, Uday R. Popat, Jack W. Hsu, Lawrence E Morris, Adam Mendizabal, William Wachsman, Nita Williams, Nidhi Sharma, Craig C Hofmeister, Stephen J. Forman, Willis H. Navarro, Joseph C. Alvarnas, Richard F. Ambinder, Carlos Malvestutto, Hannah Choe, Gregory Behbehani, Gerard Lozanski, Bradley Blaser, Robert Baiocchi
Publikováno v:
Transplantation and Cellular Therapy. 29:S67-S68
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9aceb1e138266ee68b577bf5a68c160
https://doi.org/10.1016/s2666-6367(23)00149-5
https://doi.org/10.1016/s2666-6367(23)00149-5
Autor:
Susan E Krown, Carlee B Moser, Patrick MacPhail, Roy M Matining, Catherine Godfrey, Stephanie R Caruso, Mina C Hosseinipour, Wadzanai Samaneka, Mulinda Nyirenda, Naftali W Busakhala, Fred M Okuku, Josphat Kosgei, Brenda Hoagland, Noluthando Mwelase, Vincent O Oliver, Henriette Burger, Rosie Mngqibisa, Mostafa Nokta, Thomas B Campbell, Margaret Z Borok, Agnes Moses, Cecilia Kanyama, Pamela Mukwekwerere, Ivy Gudza, Felluna Chauwa, Godwin Ulaya, Irene Kutto, Priscilla Cheruiyot, Clement Okello, Annet Nakaganda, Geoffrey Koskei, Winnie Keter, Juliana Netto, Tamiris Baião, Iveshni Govender, Jessica O'Connell-Maritz, Kevin Cain, John Okanda, Lynne Cornelissen, Marije Van Schalkwyk, Rejoice Sikhosana, Minenhle Ngcobo, Jeannette Y. Lee, Taylor Harrison, William Wachsman, Katherine Shin, Scott Evans, Jennifer Rothenberg, Lara Hosey, Sean McCarthy, Otoniel Martinez-Maza, Charles Rinaldo, Dirk Dittmer, Courtney Fletcher, Michelle Rudek, Aida Asmelash, Valery Hughes, Jeffrey Schouten, David Shugarts, Tapiwanashe Kujinga, Amanda Zadzilka, Fredrick Kerui, Debora Robertson, James Rooney, Krishna Sewal, Brian Gottshall
Publikováno v:
The Lancet. 395:1195-1207
Summary Background Optimal treatment regimens for AIDS-associated Kaposi sarcoma, a frequent contributor to morbidity and mortality among people with HIV, have not been systematically evaluated in low-income and middle-income countries, where the dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b08bb62a17bbb36e440eb3bae3392271
https://doi.org/10.1016/s0140-6736(19)33222-2
https://doi.org/10.1016/s0140-6736(19)33222-2
Autor:
Ethel Cesarman, Jeannette Y. Lee, Joseph A. Sparano, Juan Carlos Ramos, Ronald T. Mitsuyasu, Ariela Noy, William Wachsman, Amy Chadburn, David H. Henry, Richard F. Ambinder, Lawrence D. Kaplan, Lee Ratner, David M. Aboulafia
Publikováno v:
Haematologica. 106:730-735
Introduction: Six cycles of rituximab plus infusional EPOCH is considered a preferred regimen for first-line treatment of HIV-associated diffuse large B-cell lymphoma (DLBCL), HHV8-positive DLBCL, and primary effusion lymphoma, and is among the prefe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1ccfd7428e208175c04d7633da58616
https://doi.org/10.3324/haematol.2019.243386
https://doi.org/10.3324/haematol.2019.243386